Supreme Court wants cap on trade margin for all essential medicines and medical products
India’s Supreme Court has questioned the government’s proposal to cap trade margins on cancer drugs at 30%, asking whether a similar limit could apply to all medicines and medical products. The court emphasized that the government must guarantee that drugs approved by the Drug Price Control Order (DPCO) reach patients. The decision highlights the need for broader price regulation.